AMBU-VAX is a prospective, single-center observational study designed to develop and implement an organizational model for delivering recommended vaccinations within a hospital setting. The study targets adult and elderly patients with chronic diseases or immunocompromising conditions who are eligible for vaccination according to national immunization guidelines. Vaccination is actively proposed during outpatient visits, hospital admissions, or at discharge and, when accepted, administered within the hospital or coordinated with local public health vaccination services. The study aims to evaluate the feasibility, uptake, and completion of hospital-based vaccination pathways and to support integration between hospital and territorial prevention services for vulnerable populations.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Vaccination Offer Rate
Timeframe: 12 months
Vaccination Uptake Rate
Timeframe: 12 months
Number of Administered Vaccine Doses
Timeframe: 12 months
Completion of Hospital-Based Vaccination Pathway
Timeframe: 12 months
Patrizia Laurenti, Professor